Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2016-04-22 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: COLLONGES-AU-MONT-D'OR (69660), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE COLLONGES : revenue, balance sheet and financial ratios
PHARMACIE DE COLLONGES is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in COLLONGES-AU-MONT-D'OR (69660),
this company of category PME
shows in 2025 a net income positive of 100 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE COLLONGES (SIREN 819876244)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
100 226 €
79 361 €
110 062 €
108 458 €
90 800 €
87 049 €
67 789 €
56 626 €
28 829 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE COLLONGES generates positive net income of 100 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 29 k€ -> 100 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
100 226 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
28.615%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.324%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE COLLONGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
1863.87
722.401
390.511
238.336
157.207
95.967
63.34
46.362
28.615
Financial autonomy
4.423
10.476
17.279
24.739
32.467
42.066
50.413
56.642
65.324
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
28.612025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good-13 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE COLLONGES (28.61) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.32%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good+13 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE COLLONGES (65.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 286.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
286.617
Liquidity indicators evolution PHARMACIE DE COLLONGES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
189.836
190.521
196.386
216.073
225.598
225.371
240.777
259.914
286.617
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
286.622025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent+9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE COLLONGES (286.62) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE COLLONGES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE COLLONGES is estimated at
1 592 101 €
(range 1 080 407€ - 2 498 227€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1080k€1592k€2498k€
1 592 101 €Range: 1 080 407€ - 2 498 227€
NAF 5 année 2025
Valuation method used
Net Income Multiple
100 226 €
×
15.9x
=1 592 102 €
Range: 1 080 408€ - 2 498 227€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE COLLONGES with other companies in the same sector:
Frequently asked questions about PHARMACIE DE COLLONGES
What is the revenue of PHARMACIE DE COLLONGES ?
The revenue of PHARMACIE DE COLLONGES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE COLLONGES profitable?
Yes, PHARMACIE DE COLLONGES generated a net profit of 100 k€ in 2025.
Where is the headquarters of PHARMACIE DE COLLONGES ?
The headquarters of PHARMACIE DE COLLONGES is located in COLLONGES-AU-MONT-D'OR (69660), in the department Rhone.
Where to find the tax return of PHARMACIE DE COLLONGES ?
The tax return of PHARMACIE DE COLLONGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE COLLONGES operate?
PHARMACIE DE COLLONGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart